Clinical Trial

Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 7, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Determination of proteins and their levels in the vitreous of eyes with or without pseudoexfoliation syndrome (PEX)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-26.
Trial Details
NCT Number NCT07506551
Lead Sponsor Prim. Prof. Dr. Oliver Findl, MBA
Conditions Pseudoexfoliation Syndrome
Enrollment 24 participants
Start Date 2023-07-06
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-07